$AVAH

VIGANO PAUL R sold $24.0M of AVAH (indirect holdings)

VIGANO PAUL R sold 3,000,000 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $8.01 ($24.03M total) across 3 trades on 2026-06-30.

Original reporting
SEC EDGAR · VIGANO PAUL R
Published Jul 2, 2026, 4:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Bearish
medium confidence
Mentioned
$AVAH
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHBearishMed
01

Why it matters

The new information is the disclosed sale size, price ($8.0100), and that it was not under a 10b5-1 plan, which can influence short-term sentiment and risk appetite for AVAH.

02

Market read

A $24.03M insider sale at a specific price point is a fresh, tradable sentiment/risk signal, but it is not a fundamental update.

03

What to watch

The filing does not specify the reason for the sale; traders may want to check whether other insiders filed concurrent Form 4s or whether the stock’s move around $8.01 was already driven by other catalysts.

Relevance 7/10Novelty 6/10Timing: Filed 2026-07-02 after the 2026-06-30 sale at $8.01.

Background

This is an SEC Form 4 insider transaction disclosure for Aveanna Healthcare Holdings, Inc. (AVAH) by a 10% owner, reported as an indirect open-market sale.

Company-level read

Ticker impact

$AVAHBearishMedium confidence
Context

Aveanna Healthcare Holdings disclosed a 10% owner indirect open-market sale of 3,000,000 shares at $8.01 on 2026-06-30.

Expected impact

Likely mild negative/volatility around the filing window; follow-through depends on whether additional sales or new disclosures follow.

Evidence & confidence

Form 4 is primary-source and time-stamped (filed 2026-07-02) with a large notional ($24.03M) sale; however, it states no 10b5-1 plan, which can increase interpretive uncertainty rather than provide a direct fundamental catalyst.

Market effects

No direct sector read-through; this is a single-company insider transaction signal.

None indicated.

None indicated.

Counterpoint

Large insider sales can be driven by diversification, tax planning, or pre-existing personal liquidity needs rather than bearish expectations—especially when multiple trades occur at the same price.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    Subject of the Form 4 insider transaction; 10% owner sold 3,000,000 shares indirectly at $8.01.

  • VIGANO PAUL R

    10% owner who executed the indirect open-market sale; Form 4 filed 2026-07-02.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.